Researchers studying the intersection of stress, sexual function, and neuropeptide modulation may find these compounds relevant in combination research, though such protocols require rigorous independent safety review
For most GLP-1 medications, alopecia is not listed as a common adverse effect in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA)
Most notably, the top causes of human death, heart disease, diabetes, kidney disease, liver inflammation (fatty liver) but also improving joint issues that can be caused by excess weight, aging and inactivity including back, hip and knee pain and surgeries
Most users feel effects within 30-60 minutes of injection